References

American Psychiatric Association (2000) ‘Disorders usually first diagnosed in infancy, childhood, or adolescence’, in Diagnostic and statistical manual of mental disorders, 4th edn, text revision. Washington, DC: American Psychiatric Association.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Washington, DC: American Psychiatric Association.

Bailey, R.K., Jaquez-Gutierrez, M.C. and Madhoo, M. (2014) ‘Sociocultural issues in African American and Hispanic minorities seeking care for attention-deficit/hyperactivity disorder’, The primary care companion for CNS disorders, 16(4). doi: 10.4088/PCC.14r01627.

Barkley, R.A. (1997) ‘Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD’, Psychological Bulletin, 121(1), p. 65–94.

Biederman, J., Faraone, S.V., Keenan, K. et al. (1990) ‘Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder’, Journal of the American Academy of Child and Adolescent Psychiatry, 29, pp. 526–533.

Biederman J. , Faraone, S.V., Keenan, K. et al. (1992) ‘Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples’, Archives of General Psychiatry, 49, pp. 728–738.

Biederman, J., Mick, E., Faraone, S.V., Braaten, E. et al.(2002) ‘Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic’, The American Journal of Psychiatry, 159(1), pp. 36–42.

Bonvicini, C., Faraone, S.V. and Scassellati, C. (2016) ‘Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies’, Molecular Psychiatry, 21(7), p. 872–84.

Bradley, C. (1937) ‘The behavior of children receiving benzedrine’, The American Journal of Psychiatry, 94, pp. 577–585.

Cantwell, D.P. (1975) ‘Genetics of hyperactivity’, The Journal of Child Psychology and Psychiatry, 16, pp. 261–264.

Cantwell, D.P. (1996) ‘Attention deficit disorder: a review of the past 10 years’, Journal of the American Academy of Child and Adolescent Psychiatry, 35(8), pp. 978–987.

Castellanos, F.X. (1997) ‘Toward a pathophysiology of attention-deficit/hyperactivity disorder’, Clinical Pediatrics, 36, pp. 381–393.

Chen, W., Zhou, K., Sham, P. et al. (2008) ‘DSM-IV combined type ADHD shows familial association with sibling trait scores: a sampling strategy for QTL linkage’, American Journal of Medical Genetics. Part B Neuropsychiatric Genetics, 147B(8), pp. 1450–1460.

Christakou, A., Murphy, C.M., Chantiluke, K. et al. (2013) ‘Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism’, Molecular Psychiatry, 18(2), pp. 236–244.

Chuang, T.C., Wu, M.T., Huang, S.P., Weng, M.J. and Yang, P. (2013) ‘Diffusion tensor imaging study of white matter fiber tracts in adolescent attention-deficit/hyperactivity disorder’, Psychiatry Research: Neuroimaging, 211(2), pp. 186–187.

Coker, T. R., Elliott, M.N., Toomey, S.L. et al. (2016) ‘Racial and ethnic disparities in ADHD diagnosis and treatment’, Pediatrics, 138(3), p. ii.

Demontis, D., Walters, R.K., Martin, J. et al. (2017) ‘Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder’, Nature Genetics, 51, pp. 63–75. bioRxiv. doi: 10.1101/145581

Dittmann, R.W., Cardo, E., Nagy, P., Anderson, C.S. et al. (2013) ‘Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study’, CNS Drugs, 27(12), pp. 1081–1092.

Doggett, A. M. (2004) ‘ADHD and drug therapy: is it still a valid treatment?’, Journal of Child Health Care, 8(1), pp. 69–81.

Faraone, S.V. and Larsson, H. (2019) ‘Genetics of attention deficit hyperactivity disorder’, Molecular Psychiatry, 24, pp. 562–575.

Faraone, S. V., Biederman, J. and Mick, E. (2006) ‘The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies’, Psychological Medicine, 36(2), pp. 159–165.

Flicek, M. (1992) ‘Social status of boys with both academic problems and attention-deficit hyperactivity disorder’, Journal of Abnormal Child Psychology, 20(4), pp. 353–366.

Frazier, T. W., Demaree, H.A. and Youngstrom, E.A. (2004) ‘Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder’, Neuropsychology, 18(3), pp. 543–555.

Gaub, M. and Carlson, C.L. (1997) ‘Gender differences in ADHD: a meta-analysis and critical review’, Journal of the American Academy of Child and Adolescent Psychiatry, 36(8), pp. 1036–1045.

Gizer, I. R., Ficks, C. and Waldman, I.D. (2009) ‘Candidate gene studies of ADHD: a meta-analytic review’, Human Genetics, 126(1), pp. 51–90.

Gonon, F. (2009) ‘The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining’, Trends in Neurosciences, 32(1), pp. 2–8.

Hansen, B. H., Oerbeck, B., Skirbekk, B. et al. (2018) ‘Neurodevelopmental disorders: prevalence and comorbidity in children referred to mental health services’, Nordic Journal of Psychiatry, 72(4), pp. 285–291.

Harpin, V. A. (2005) ‘The effect of ADHD on the life of an individual, their family, and community from preschool to adult life’, Archives of Disease in Childhood, 90(1), i2–i7.

Hart, H., Radua, J., Mataix-Cols, D. and Rubia, K. (2012) ‘Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD)’, Neuroscience and Biobehavioral Reviews, 36(10), pp. 2248–2256.

Hodgkins, P. S., Montejano, L.B., Sasané, R. and Huse, D.M. (2011) ‘Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis’, The Primary Care Companion for CNS Disorders, 13(2).

Johansson, J., Landgren, M., Fernell, E. et al. (2013) ‘Decreased binding capacity (Bmax) of muscarinic acetylcholine receptors in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD)’, Attention Deficit and Hyperactivity Disorders, 5(3), pp. 267–271.

Jones, K., Daley, D., Hutchings, J. et al. (2007) ‘Efficacy of the Incredible Years Basic parent training programme as an early intervention for children with conduct problems and ADHD’, Child: Care, Health and Development, 33(6), pp. 749–756.

Kebir, O., Tabbane, K., Sengupta, S. and Joober, R. (2009) ‘Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies’, Journal of Psychiatry & Neuroscience, 34(2), pp. 88–101.

Lachaine, J., Beauchemin, C., Sasane, R. and Hodgkins, P.S. (2012) ‘Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective’, Postgraduate Medicine, 124(3), pp. 139–148.

Larson, K., Russ, S.A., Kahn, R.S. and Halfon, N. (2011) ‘Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007’, Pediatrics, 127(3), p. 462–470.

Levy, F. (1991) ‘The dopamine theory of attention deficit hyperactivity disorder (ADHD)’, Australian and New Zealand Journal of Psychiatry, 25(2), pp. 277–283.

Li, D., Sham, P.C., Owen M.J. and Lin, H (2006) ‘Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)’, Human Molecular Genetics, 15(14), pp. 2276–2284.

Madras, B.K., Miller, G.M. and Fischman, A.J. (2002) ‘The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)’, Behavioural Brain Research, 130(1–2), pp. 57–63.

Mariani, J. J. and Levin, F.R. (2007) ‘Treatment strategies for co-occurring ADHD and substance use disorders’, The American Journal on Addictions, 16(1), pp. 45–56.

Matza, L. S., Paramore, C. and Prasad, M. (2005) ‘A review of the economic burden of ADHD’, Cost Effectiveness and Resource Allocation, 3(1), p. 5.

Moffitt, T.E., Houts, R., Asherson, P. et al. (2015) ‘Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study’, The American Journal of Psychiatry, 172(10), pp. 967–977.

Mofokeng, M. and van der Wath, A.E. (2017) ‘Challenges experienced by parents living with a child with attention deficit hyperactivity disorder’, Journal of Child Adolescent Mental Health, 29(2), pp. 137–145.

Montagni, I., Guichard, E. and Kurth, T. (2016) ‘Association of screen time with self-perceived attention problems and hyperactivity levels in French students: a cross-sectional study’, BMJ Open, 6(2), e009089.

Mostofsky, S.H., Cooper, K.L., Kates, W.R. et al. (2002) ‘Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder’, Biological Psychiatry, 52(8), pp. 785–794.

Mueller, A., Hong, D. S., Shepard, S. and Moore, T. (2017) ‘Linking ADHD to the neural circuitry of attention’, Trends in Cognitive Sciences, 21(6), pp. 474–488.

National Institute for Health and Care Excellence (NICE) (2018) Attention deficit hyperactivity disorder: diagnosis and management, NICE Guideline 87. Available at: https://www.nice.org.uk/guidance/ng87 (Accessed: 27 September 2019).

Newcorn, J. H., Kratochvil, C. J., Allen, A. J. et al. and Atomoxetine/Methylphenidate Comparative Study Group (2008) ‘Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response’, The American Journal of Psychiatry, 165(6), pp. 721–730.

Nøvik, T. S., Hervas, A., Ralston, S.J. et al. and ADORE Study Group (2006) ‘Influence of gender on attention-deficit/hyperactivity disorder in Europe – ADORE’, European Child and Adolescent Psychiatry, 15(1), pp. i15–i24.

Pettersson, R., Söderström, S., Edlund-Söderström, K., Nilsson, K.W. (2017) ‘Internet-based cognitive behavioural therapy for adults with ADHD in outpatient psychiatric care: a randomized trial’. Journal of Attention Disorders, 21: 508-521.

Polanczyk, G., De Lima, M. S., Horta, B. L. et al. (2007) ‘The worldwide prevalence of ADHD: a systematic review and metaregression analysis’, The American Journal of Psychiatry, 164(6), pp. 942–948.

Reale, L., Bartoli, B., Cartabia, M. et al. and Lombardy ADHD Group (2017) ‘Comorbidity prevalence and treatment outcome in children and adolescents with ADHD’, European Child & Adolescent Psychiatry, 26(12), pp. 1443–1457.

Rubia, K., Alegría, A. A. and Brinson, H. (2014) ‘Brain abnormalities in attention-deficit hyperactivity disorder: a review’, Revista de Neurologia, 58(1), S3–16.

Sciberras, E., Mulraney, M., Silva, D. and Coghill, D. (2017) ‘Prenatal Risk Factors and the Etiology of ADHD – Review of Existing Evidence’, Current Psychiatry Reports, 19(1), p. 1.

Setyawan, J., Hodgkins, P., Guérin, A. et al. (2013) ‘Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis’, Journal of Medical Economics, 16(7), pp. 962–975.

Shaw, P., Eckstrand, K., Sharp, W. et al. (2007) ‘Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation’, Proceedings of the National Academy of Sciences of the United States of America, 104(49), pp. 19649–19654.

Shaw, P., Malek, M., Watson, B.et al. (2013) ‘Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder’, Biological Psychiatry, 74(8), pp. 599–606.

Solanto, M.V. (1998) ‘Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration’, Behavioural Brain Research, 94(1), pp. 127–152.

Sonuga-Barke, E.J., Daley, D., Thompson, M. et al. (2001) ‘Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample’, Journal of the American Academy of Child and Adolescent Psychiatry, 40(4), pp. 402–408.

Spencer, T. J., Biederman, J., Wilens, T. E. and Faraone, S.V. (2002) ‘Overview and neurobiology of attention-deficit/hyperactivity disorder’, The Journal of Clinical Psychiatry, 63 (12), pp. 3–9.

Sprich, S., Biederman, J., Crawford, M.H. et al. (2000) ‘Adoptive and biological families of children and adolescents with ADHD’, Journal of the American Academy of Child and Adolescent Psychiatry, 39(11), pp. 1432–1437.

Swing, E. L., Gentile, D. A., Anderson, C.A. and Walsh, D. A. (2010) ‘Television and video game exposure and the development of attention problems’, Pediatrics, 126(2), pp. 214–221.

Virani, A. (2005) ‘Perspectives in psychopharmacology: spotlight on atomoxetine’, The Canadian Child and Adolescent Psychiatry Review, 14(4), p. 96–98.

Wallis, D., Arcos-Burgos, M., Jain, M. et al.(2009) ‘Polymorphisms in the neural nicotinic acetylcholine receptor α4 subunit (CHRNA4) are associated with ADHD in a genetic isolate’, ADHD Attention Deficit and Hyperactivity Disorders, 1(1), pp. 19–24.

Webster-Stratton, C. and Hancock, L. (1998) ‘Parent training for young children with conduct problems. Content, methods and therapeutic process’, in Schaefer, C.E. (ed.) Handbook of parent training. New York, NY: John Wiley & Sons, pp. 98–152.

Wehmeier, P. M., Schacht, A. and Barkley, R. A. (2010) ‘Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life’, The Journal of Adolescent Health, 46(3), pp. 209–217.

Weisman, O., Schonherz, Y., Harel, T. et al. (2017) ‘Testing the efficacy of a smartphone application in improving medication adherence, among children with ADHD’, European Neuropsychopharmacology, 27(2), S1113.